1. Home
  2. NPWR vs ACIU Comparison

NPWR vs ACIU Comparison

Compare NPWR & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NET Power Inc.

NPWR

NET Power Inc.

HOLD

Current Price

$1.70

Market Cap

193.9M

Sector

Energy

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$3.03

Market Cap

213.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPWR
ACIU
Founded
2010
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.9M
213.3M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
NPWR
ACIU
Price
$1.70
$3.03
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$3.50
$10.00
AVG Volume (30 Days)
554.6K
240.0K
Earning Date
05-11-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$706.75
Revenue Next Year
N/A
$321.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.46
$1.45
52 Week High
$5.20
$4.00

Technical Indicators

Market Signals
Indicator
NPWR
ACIU
Relative Strength Index (RSI) 52.46 50.44
Support Level $1.64 $2.56
Resistance Level $1.80 $3.46
Average True Range (ATR) 0.10 0.20
MACD 0.03 0.02
Stochastic Oscillator 62.03 51.60

Price Performance

Historical Comparison
NPWR
ACIU

About NPWR NET Power Inc.

NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: